コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 NAA and NAAG as well as aspartoacylase (ASPA), the enzym
2 NAA may be an important risk modifier for methylation in
3 NAA was the metabolite characterized by the greatest reg
4 NAA, Cr, Cho, NAA/Cr, NAA/Cho, and Cho/Cr values were ev
5 NAA-RFs are photonic crystal structures produced by sinu
6 NAA/Cho and Cho/Cr ratios correlated with the scaled gro
7 NAA/Cr in the high-dose davunetide group (N=8) suggested
8 NAA/Cr was unchanged for combined high- and low-dose dav
10 ent from delta (15)Nbulk data, and delta (15)NAA data suggest that two insectivorous species (Lasiuru
11 her terrestrial organisms and that delta (15)NAA provides a reliable approach for addressing question
12 sotopes of individual amino acids (delta (15)NAA) and bulk-tissue carbon (delta (13)Cbulk) and nitrog
13 ive was to assess the precision of delta (15)NAA-based estimates of TP relative to other approaches.
19 nchyma showed decreases in N-acetylasparate (NAA) and tissue water T2, and increases in choline-conta
20 zed the concentrations of N-acetylaspartate (NAA) and choline (Cho) in each ROI to the concentration
22 natural 13C abundance of N-acetylaspartate (NAA) and the appearance of 13C-labeled glutamate, glutam
23 It is unclear whether N-acetylaspartate (NAA) depletions documented in schizophrenia patients mig
28 elevated choline (Cho)-to-N-acetylaspartate (NAA) ratio (hereafter, Cho/NAA ratio) and whether their
29 f the neuronal metabolite N-acetylaspartate (NAA) was measured in the human normal-appearing corpus c
30 diffusion coefficient of N-acetylaspartate (NAA) was significantly elevated, suggesting intra-axonal
31 (Cr), choline (Cho), and N-acetylaspartate (NAA) were segmented into 81 regions with Automated Anato
33 examine concentrations of N-acetylaspartate (NAA), a marker of neuronal integrity and function, and c
34 Studies indicate that N-acetylaspartate (NAA), a marker of neuronal integrity, and choline, a mar
36 e (Glu), glutamine (Gln), N-acetylaspartate (NAA), and choline (Cho) levels in the right and left pos
37 nd lower brain glutamate, N-acetylaspartate (NAA), and creatine concentrations in MSUD patients, whic
38 e (ATP, ATP-catabolites), N-acetylaspartate (NAA), antioxidant defenses (ascorbic acid, glutathione),
39 nal integrity measured by N-acetylaspartate (NAA), brain volume, and clinical outcomes in a large, pr
42 30) and smokers (n = 35), N-acetylaspartate (NAA), choline-containing compounds, creatine-containing
43 te rostral and caudal ACC N-acetylaspartate (NAA), creatine (Cr), and choline (Cho) concentrations.
44 th p < 0.05); for lactate/N-acetylaspartate (NAA), only xenon-augmented hypothermia reduced the slope
45 opy to measure prefrontal N-acetylaspartate (NAA), which is mainly localized in neurons, and total cr
47 with thalamic volumes and N-acetylaspartate (NAA)/choline (Cho), and fractional anisotropy of white-m
48 egnancies, a reduction in N-acetylaspartate (NAA)/choline ratio and detection of lactate methyl are e
49 gle voxel (basal ganglia) N-acetylaspartate (NAA)/Choline, NAA/Creatine and myo-inositol/Creatine rat
50 ation between hippocampal N-acetylaspartate (NAA)/Cr and Glx/Cr in patients with schizophrenia were f
51 maps (choline, creatine, N-acetylaspartate [NAA], and/or citrate), and statistical analysis involvin
52 DTS to study metabolite (N-acetylaspartate, NAA) diffusion within axons in patients with BDP (n=21)
53 , galactose, and an N-acetylated amino acid (NAA), showed a high sensitivity (86.9% [75.8-94.2]) and
54 ts; brain volume and N-acetyl aspartic acid (NAA) decreased steadily, but no published quantitative M
55 ic acid (BTOA) and 1-naphthaleneacetic acid (NAA), into the active site indicates that NAA and BTOA a
58 fS) combined with nanoporous anodic alumina (NAA) platforms when detecting different analytes under d
59 uberculosis (TB) nucleic acid amplification (NAA) tests and the clear benefits of immediate diagnosis
60 as compared with nucleic acid amplification (NAA)-based assays for determining the etiology of vagini
63 ignificant reductions of NAA (P < 0.001) and NAA/Cr + Pcr (P < 0.001), and significant improvement in
67 sample, higher NAA and Glu in the DLPFC and NAA concentrations in multiple lobar gray matter and whi
69 opy at 3T to longitudinally estimate Glu and NAA concentrations from large areas of normal-appearing
71 previous reports, we tested whether GMV and NAA/Cr in the dorsolateral prefrontal cortex are associa
72 ptoms was the main predictor of both GMV and NAA/Cr in the left dorsolateral prefrontal cortex of pat
73 re pain was associated with reduced GMVs and NAA/Cr, over and above the effects of fatigue, depressiv
74 at baseline than in control individuals, and NAA levels were significantly correlated with pain-sympt
75 c NAA, we investigated the effect of NAA and NAA-producing B cells in disease development in the auto
78 te and N-acetylaspartyl glutamate (summed as NAA) fell steadily during the infusion by 8 +/- 3% (p =
80 els of the neuron marker N-acetyl aspartate (NAA), along with higher levels of glutamate (Glu) and Gl
81 ain metabolite levels of N-acetyl aspartate (NAA), choline (tCHO), creatine (CR), myoinositol (MI), a
82 MRS metabolite ratios of N-acetyl aspartate (NAA)/creatine (Cr), NAA/myoinositol (mI), and mI/Cr meas
84 l metabolites, including N-acetyl-aspartate (NAA), an amino acid exclusively synthesized in the mitoc
86 Genetic suppression of N-acetyl-l-aspartate (NAA) synthesis, previously shown to block brain vacuolat
87 endroglia that cleaves N-acetyl-l-aspartate (NAA) to acetate and l-aspartic acid, elevates brain NAA
88 at prevent cleavage of N-acetyl-L-aspartate (NAA), resulting in marked elevations in central nervous
89 phocreatine [PCr] to Pi, N-acetyl aspartate [NAA] to creatine [Cr], and lactate to Cr) and diffusion-
90 rked decrease in the cerebral levels of ATP, NAA, ascorbic acid, glutathione and NAD(+) and a signifi
94 detected no significant correlations between NAA alterations and PANSS-P (P = 0.679) or PANSS-G (P =
95 Z and HC were apparent, correlations between NAA/Cr and Glx/Cr in healthy subjects in the hippocampus
101 acetate and l-aspartic acid, elevates brain NAA and causes "spongiform" vacuolation of superficial b
104 T infants had significantly lower cerebellar NAA (p < 0.025) and higher Cho (p < 0.001) at TEA when c
106 n the OSA and the control group for NAA/Cho, NAA/Cr and Cho/Cr ratios for both hippocampal regions.
108 these normalized metabolites (i.e., NAA/Cho, NAA/norCre, and Cho/norCre) by averaging all patients an
110 ratio of choline to N-acetyl-aspartate (Cho/NAA) may provide additional information on tumor extent
111 and nonenhancing regions showed elevated Cho/NAA ratios, which were significantly higher than those i
112 -acetylaspartate (NAA) ratio (hereafter, Cho/NAA ratio) and whether their volumes correlated with pro
113 onclusion:(18)F-FET uptake and increased Cho/NAA ratio are not always congruent and may represent dif
114 lumes for (18)F-FET uptake and increased Cho/NAA were 19 +/- 20 cm(3) (mean +/- SD) and 22 +/- 24 cm(
115 mass in (18)F-FET PET and MRS imaging of Cho/NAA, determined by simultaneously acquired, 3-dimensiona
116 al ganglia) N-acetylaspartate (NAA)/Choline, NAA/Creatine and myo-inositol/Creatine ratios were measu
118 The diagnostic accuracy of the combined NAA-based test construct was approximately 20 to 25% hig
119 onstrates that the proposed system combining NAA-RFs with RfS has outstanding capabilities to develop
122 reatine (Cr) and N-acetylaspartyl compounds (NAA) and standardised neuropsychological test scores.
124 A/Cr + Pcr (P = 0.500) compared to controls; NAA levels were negatively correlated with PANSS total s
125 When lesion volume was added as a covariate, NAA also showed a significant correlation with executive
126 In patients with CSM, NAA normalized to Cr (NAA/Cr) levels were significantly lower 6 months after s
127 s of N-acetyl aspartate (NAA)/creatine (Cr), NAA/myoinositol (mI), and mI/Cr measured in the posterio
131 cts of davunetide on change in NAA/creatine (NAA/Cr) and choline/creatine (choline/Cr) over 12 weeks
133 tion of increased Cho/Cr ratio and decreased NAA/Cho ratio predicted impaired motor outcome at a corr
134 Intact white matter integrity with decreased NAA/Cr levels suggests that mitochondrial metabolic dysf
136 PANSS-G (P = 0.668) symptom changes; nor did NAA/Cr + Pcr changes with alterations in PANSS-P (P = 0.
137 nefits of immediate diagnosis of TB disease, NAA tests frequently are not used in the diagnosis of pu
140 rated greater age-related decreases of DLPFC NAA and anterior cingulate cortex and DLPFC Glu levels.
141 d suggests the existence of the NAT8L-driven NAA metabolism as a novel pathway to provide cytosolic a
142 atios of these normalized metabolites (i.e., NAA/Cho, NAA/norCre, and Cho/norCre) by averaging all pa
146 ed nanoporous anodic alumina photonic films (NAA-PFs) and reflectometric interference spectroscopy (R
147 of nanoporous anodic alumina rugate filters (NAA-RFs) for real-time and label-free biosensing applica
148 ng nanoporous anodic alumina rugate filters (NAA-RFs) modified with human serum albumin (HSA) and ref
150 of Public Health Laboratory would allow for NAA test identification of approximately 54 (74%) of 72
155 es between the OSA and the control group for NAA/Cho, NAA/Cr and Cho/Cr ratios for both hippocampal r
156 e a strategy for identifying individuals for NAA testing on the basis of nonclinical risk criteria th
157 toacylase (ASPA), the enzyme responsible for NAA degradation, are significantly reduced in glioma tum
158 re, we demonstrate that acetate derived from NAA is not essential for myelin lipid synthesis and that
163 ease the rate of NAA decline, and higher Glu/NAA[NAWM] ratio increases the rate of decline of brain v
166 e examined together in relation to right Glu/NAA, only re-experiencing symptoms remained a significan
168 -aspartate plus N-acetyl-aspartyl-glutamate (NAA) to creatine (Cr) and choline compounds (Cho) to Cr
169 AA concentrations at 3 to 4 years of age; GM NAA concentrations remained reduced at 9 to 10 years of
171 een the ASD and DD groups in the rates of GM NAA, Cho, and Cr changes between 3 and 10 years of age.
173 ngs in the stuttering sample included higher NAA:Cr and Cho:Cr ratios (regression coefficient, 197.4-
175 rior cingulate cortex (ACC) and hippocampus; NAA/Cr and glutamate + glutamine (Glx)/Cr ratios were ob
177 plore the effects of davunetide on change in NAA/creatine (NAA/Cr) and choline/creatine (choline/Cr)
178 udinal decline in NAA[GM] (-0.06mM change in NAA[GM] /yr for each unit increase in Glu; p = 0.004).
180 ctive of accelerated longitudinal decline in NAA[GM] (-0.06mM change in NAA[GM] /yr for each unit inc
181 n myo-inositol occurs before the decrease in NAA in hippocampus but not cortex; the hippocampus shows
183 gs support the hypothesis that a decrease in NAA/Cr is associated with loss of synapses and early pTa
184 ents presented no significant differences in NAA (P = 0.084) or NAA/Cr + Pcr (P = 0.500) compared to
185 sed in relation to a significant increase in NAA/norCre and a decrease in Cho/norCre; interestingly,
186 tide appeared to produce modest increases in NAA/Cr and choline/Cr in DLPFC in people with schizophre
188 levels and the lack of decreasing trends in NAA with age in the 22q11DS group relative to control su
190 WM] was predictive of a loss of 0.28mM/yr in NAA[NAWM] (p < 0.001) and 0.15mM/yr in NAA[GM] (p = 0.05
191 s, and parietal white matter with increasing NAA and glutamate and decreasing myoinositol and choline
193 ted to reported pain, left posterior insular NAA and Cho levels were significantly higher at baseline
194 extracellular NAAG is rapidly converted into NAA and glutamate by the catalytic enzyme glutamate carb
195 y on mGluR3 and by reducing degradation into NAA and glutamate resulting in reduced cell death in mod
197 rporation from corresponding substrates into NAA and NAAG, and the other involving the measurement of
199 erence fringe pattern about the mid-latitude NAA transmitter is due to a 3 km reduction in the effect
200 nly one intact Nat8L allele accumulated less NAA, developed a less severe pathology, phenotypic impro
204 mpal cortices and amygdala, as well as lower NAA:Cr and Cho:Cr ratios (regression coefficient, 119.8-
205 years of age, the ASD group exhibited lower NAA, Cho, and Cr concentrations than did the TD group in
207 PTSD patients exhibited significantly lower NAA in right and left hippocampi, and significantly high
208 by early pain (before scan 1), whereas lower NAA/choline was predicted by pain exposure throughout th
212 est-based findings included lower group mean NAA:Cr ratio in stuttering than nonstuttering participan
214 on brain volume, prompting the use of the mI:NAA ratio in normal-appearing white matter as a predicto
217 i.e., sensing principle) of gelatin-modified NAA-PFs (i.e., sensing element) during enzymatic digesti
219 verify that the combination of HSA-modified NAA-RFs with RIfS can be used as a portable, low-cost, a
220 treatment induces an acute reduction of MPFC NAA during the early phase of schizophrenia, which may b
223 u concentrations and lower lenticular nuclei NAA level; smokers also demonstrated greater age-related
226 TR and the apparent diffusion coefficient of NAA correlated with more adverse outcomes in the patient
228 s suggest that lowering the concentration of NAA in the brains of children with Canavan disease would
230 rototypic NAA, we investigated the effect of NAA and NAA-producing B cells in disease development in
231 a reason for the increased effectiveness of NAA and BTOA as auxins in planta and provides a tool for
232 This study sought to examine the effects of NAA and NAAG on primary tumor-derived glioma stem-like c
236 wever, indicates that complete inhibition of NAA synthase may bear unforeseeable risks for the patien
238 for myelin lipid synthesis and that loss of NAA-derived acetate does not cause the myelin phenotype
239 s models, Glu was examined as a predictor of NAA decline, annualized percentage brain volume change,
240 gher Glu concentrations increase the rate of NAA decline, and higher Glu/NAA[NAWM] ratio increases th
242 ients demonstrated significant reductions of NAA (P < 0.001) and NAA/Cr + Pcr (P < 0.001), and signif
244 GSC malignancy and suggests that the use of NAA or NAAG is not an appropriate therapeutic approach t
247 etween caudal and rostral measurements, only NAA in patients was different from that in control subje
250 ignificant differences in NAA (P = 0.084) or NAA/Cr + Pcr (P = 0.500) compared to controls; NAA level
254 nsgenic (sd-tg) mice expressing a prototypic NAA, we investigated the effect of NAA and NAA-producing
257 culated N-acetylaspartate to choline ratios (NAA/choline), lactate to choline ratios, average diffusi
258 RS with the assessment of metabolite ratios (NAA/Cr, Cho/Cr, mI/Cr), as well as DTI with evaluation o
259 creased Cho/Cr ratio (P < .03) and a reduced NAA/Cho ratio (P < .01) compared to those without impair
260 more cell membrane per unit volume, reduced NAA in ACC appears to be coupled with increases in overa
262 B cases over a 1-year period while requiring NAA testing for only 933 (17%) of 5,469 individuals subm
264 re negatively correlated with left and right NAA, and positively correlated with right Glu and right
265 showed no rearing effects for NAA, but right NAA was positively related to body mass, irrespective of
266 icant differences between caudal and rostral NAA concentration are found in ACC of patients with schi
267 lic health laboratories primarily perform TB NAA tests only on a targeted subset of specimens, usuall
268 o targeted testing, some laboratories use TB NAA tests universally for all respiratory specimens, tho
269 pain was associated with decreased thalamic NAA/Cho and microstructural alterations in thalamocortic
272 Our data clearly support the hypothesis that NAA accumulation is the major factor in the development
274 ating characteristic analysis indicated that NAA/Cho in tumor shows a high prediction to 6-month over
275 d (NAA), into the active site indicates that NAA and BTOA are likely to be poor substrates for this e
280 istically significant difference between the NAA and Cho levels in the acute kernicterus patients and
281 by an inability to identify the gene for the NAA biosynthetic enzyme aspartate N-acetyltransferase (A
283 low frequency radiowave observations of the NAA 24.0 kHz transmitter, Cutler, Maine, made from Halle
284 on from lupus nephritis and suggest that the NAA B cells may have an immune regulatory function via t
285 ing and T2 at MR imaging correlated with the NAA/Cho ratio (P < .05 for both) but not with the Cho/Cr
286 oncentrations including Glx (Glu+Gln), tNAA (NAA+NAAG), mI all had coefficient of variations between
289 correlated with clinical stage of HCC, were NAA, dimethylglycine, 1-methylnicotinamide, methionine,
291 e in the amygdala, cortex and striatum while NAA decreased only in the hippocampus and cortex at 17-2
293 tal infection was negatively associated with NAA and Cr (p < 005), while cerebral cortical brain inju
300 The DD group exhibited reduced GM and WM NAA concentrations at 3 to 4 years of age; GM NAA concen
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。